Basic Information
AdaptVac is a joint venture between ExpreS2ion Biotech and NextGen Vaccines, a spin-off from the University of Copenhagen, aimed at accelerating the development of safe and effective therapeutic and preventive vaccines for treating and preventing specific cancers, infectious diseases, and immune disorders.
AdaptVac ApS
RegionZealand,Denmark
less than 15 people
January 01, 2017
info@adaptvac.com
Enterprise Profile
Industrial Sector
Technology
Concept
Application Scenarios